AK-Trol Interactions
There are 98 drugs known to interact with AK-Trol (dexamethasone / neomycin / polymyxin b ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, 50 are moderate, and 47 are minor.
- View AK-Trol disease interactions (2)
Medications known to interact with AK-Trol
Note: Showing generic names only.
A
- acarbose
- acetohexamide
- adagrasib
- albiglutide
- alogliptin
- amikacin
- amikacin liposome
- amprenavir
- atazanavir
B
C
- canagliflozin
- ceritinib
- chloramphenicol
- chlorpropamide
- clarithromycin
- cobicistat
- conivaptan
- cyclosporine ophthalmic
D
E
F
G
I
- idelalisib
- indinavir
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- itraconazole
K
L
M
N
P
R
S
- saquinavir
- saxagliptin
- semaglutide
- sitagliptin
- smallpox vaccine
- sotagliflozin
- streptomycin
- suprofen ophthalmic
T
- telaprevir
- telithromycin
- tirzepatide
- tobramycin
- tolazamide
- tolbutamide
- troglitazone
- troleandomycin
- tucatinib
V
AK-Trol disease interactions
There are 2 disease interactions with AK-Trol (dexamethasone / neomycin / polymyxin b ophthalmic) which include:
Report options
QR code containing a link to this page
More about AK-Trol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.